NR4A1 and neoplasm: In those that report on receptor status, hormone receptor positive tumours were less likely to achieve pathological complete response to chemoradiation (chemoRT) than other subtypes [25,26], which is unsurprising given the better complete pathological response rates following chemotherapy for higher risk subgroups.